Optimer Wins EU Approval for New Antibiotic – Xconomy

Optimer Wins EU Approval for New Antibiotic
Xconomy
Optimer and Astellas are hoping to capitalize on the opportunity to fight C. difficile, a hardy bug that causes diarrhea so severe it can be fatal. Optimer's drug is designed to specifically kill this bug, while sparing most of the healthy bacteria in
The European Commission Grants Marketing Authorization for DIFICLIR PR Newswire (press release)

all 18 news articles »

diarrhea – Google News